Oxycodone Patent Expiration

Oxycodone is Used for managing severe, chronic pain when other treatment options are insufficient. It was first introduced by Collegium Pharmaceutical Inc in its drug Xtampza Er on Apr 26, 2016.


Oxycodone Patents

Given below is the list of patents protecting Oxycodone, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Xtampza Er US10004729 Tamper-resistant pharmaceutical compositions of opioids and other drugs Dec 10, 2030 Collegium Pharm Inc
Xtampza Er US10188644 Process of making stable abuse-deterrent oral formulations Sep 02, 2036 Collegium Pharm Inc
Xtampza Er US10525052 Abuse-deterrent drug formulations Jul 07, 2023

(Expired)

Collegium Pharm Inc
Xtampza Er US10525053 Abuse-deterrent pharmaceutical compositions of opioids and other drugs Jul 07, 2023

(Expired)

Collegium Pharm Inc
Xtampza Er US10646485 Process of making stable abuse-deterrent oral formulations Sep 02, 2036 Collegium Pharm Inc
Xtampza Er US10668060 Tamper-resistant pharmaceutical compositions of opioids and other drugs Dec 10, 2030 Collegium Pharm Inc
Xtampza Er US7399488 Abuse-deterrent pharmaceutical compositions of opiods and other drugs Mar 24, 2025 Collegium Pharm Inc
Xtampza Er US7771707 Abuse-deterrent drug formulations Mar 24, 2025 Collegium Pharm Inc
Xtampza Er US8449909 Abuse-deterrent drug formulations Mar 24, 2025 Collegium Pharm Inc
Xtampza Er US8557291 Abuse-deterrent pharmaceutical compositions of opioids and other drugs Mar 21, 2025 Collegium Pharm Inc
Xtampza Er US8758813 Abuse-deterrent drug formulations Jun 10, 2025 Collegium Pharm Inc
Xtampza Er US8840928 Tamper-resistant pharmaceutical compositions of opioids and other drugs Jul 07, 2023

(Expired)

Collegium Pharm Inc
Xtampza Er US9044398 Abuse-deterrent pharmaceutical compositions of opiods and other drugs Jul 07, 2023

(Expired)

Collegium Pharm Inc
Xtampza Er US9248195 Abuse-deterrent pharmaceutical compositions of opioids and other drugs Jul 07, 2023

(Expired)

Collegium Pharm Inc
Xtampza Er US9592200 Abuse-deterrent pharmaceutical compositions of opioids and other drugs Jul 07, 2023

(Expired)

Collegium Pharm Inc
Xtampza Er US9682075 Tamper-resistant pharmaceutical compositions of opioids and other drugs Dec 10, 2030 Collegium Pharm Inc
Xtampza Er US9737530 Process of making stable abuse-deterrent oral formulations Sep 02, 2036 Collegium Pharm Inc
Xtampza Er US9763883 Abuse-deterrent drug formulations Jul 07, 2023

(Expired)

Collegium Pharm Inc
Xtampza Er US9968598 Process of making stable abuse-deterrent oral formulations Sep 02, 2036 Collegium Pharm Inc


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Oxycodone's patents.

Given below is the list recent legal activities going on the following patents of Oxycodone.

Event Date Patent/Publication
Patent litigations
Second letter to regulating agency to determine regulatory review period 20 Mar, 2024 US7771707
Second letter to regulating agency to determine regulatory review period 20 Mar, 2024 US7399488
Requirement for information sent under 37 CFR 1.750 20 Mar, 2024 US7771707
Second letter to regulating agency to determine regulatory review period 20 Mar, 2024 US8449909
Expire Patent 12 Feb, 2024 US10525053
Payment of Maintenance Fee, 4th Yr, Small Entity 15 Nov, 2023 US10668060
Payment of Maintenance Fee, 4th Yr, Small Entity 25 Oct, 2023 US10646485
Letter from FDA or Dept of Agriculture re PTE application 19 Oct, 2023 US7399488
Letter from FDA or Dept of Agriculture re PTE application 19 Oct, 2023 US7771707
Maintenance Fee Reminder Mailed 28 Aug, 2023 US10525053



Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳